Immunosuppressive CD14⁺HLA‐DR^low/− monocytes in prostate cancer

Abstract

This is the first report of CD14(+) cells exhibiting reduced expression of HLA-DR molecules in PCa patients. These cells suppress immune cell function in vitro and, plausibly, in vivo, a finding that must be factored into the design of immunotherapy protocols for PCa patients.